114 related articles for article (PubMed ID: 3879751)
1. Gentisate, a salicylate metabolite with antioxidant properties.
Cleland LG; Whitehouse MW; Betts WH
Drugs Exp Clin Res; 1985; 11(8):463-7. PubMed ID: 3879751
[TBL] [Abstract][Full Text] [Related]
2. Plasma and synovial fluid gentisate in patients receiving salicylate therapy.
Cleland LG; Lowthian PJ; Imhoff D; Bochner F; Betts WH; O'Callaghan J
J Rheumatol; 1985 Feb; 12(1):136-9. PubMed ID: 3981499
[TBL] [Abstract][Full Text] [Related]
3. [Kinetics of salicylates from the blood to the articular fluid].
Soren A
Rev Rhum Mal Osteoartic; 1978 Mar; 45(3):165-9. PubMed ID: 653293
[TBL] [Abstract][Full Text] [Related]
4. Transport of salicylates from blood to joint fluid.
Soren A
Arch Intern Med; 1973 Nov; 132(5):668-72. PubMed ID: 4750223
[No Abstract] [Full Text] [Related]
5. Time for salicylate diffusion from blood to joint fluid. A study of histopathology of the synovial membrane.
Soren A
Reumatismo; 1977; 29(1):1-6. PubMed ID: 618099
[No Abstract] [Full Text] [Related]
6. Kinetics of salicylates in blood and joint fluid.
Soren A
J Clin Pharmacol; 1975; 15(2-3):173-7. PubMed ID: 1123459
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of acetylsalicylic acid in blood and joint fluid.
Soren A
Scand J Rheumatol; 1977; 6(1):17-22. PubMed ID: 850778
[TBL] [Abstract][Full Text] [Related]
8. Plasma and synovial fluid concentrations of salicylic acid and its metabolites in patients with joint effusions.
Sitar DS; Chalmers IM; Hunter T
J Rheumatol; 1985 Feb; 12(1):134-5. PubMed ID: 3981498
[TBL] [Abstract][Full Text] [Related]
9. [Transport of salicylates from blood to joint fluid (author's transl)].
Soren A
Wien Klin Wochenschr; 1977 Sep; 89(17):599-602. PubMed ID: 906524
[TBL] [Abstract][Full Text] [Related]
10. Salicylate metabolites in synovial fluid.
Simkin PA
J Rheumatol; 1986 Apr; 13(2):462-3. PubMed ID: 3723510
[No Abstract] [Full Text] [Related]
11. Comparative tissue absorption of oral 14C-aspirin and topical triethanolamine 14C-salicylate in human and canine knee joints.
Rabinowitz JL; Feldman ES; Weinberger A; Schumacher HR
J Clin Pharmacol; 1982 Jan; 22(1):42-8. PubMed ID: 6977559
[TBL] [Abstract][Full Text] [Related]
12. Characterization of salicylate binding to synovial fluid and plasma protein in patients with rheumatoid arthritis.
Trnavská Z; Trnavský K
Eur J Clin Pharmacol; 1980 Nov; 18(5):403-6. PubMed ID: 7439262
[TBL] [Abstract][Full Text] [Related]
13. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
Arthritis Res Ther; 2005; 7(4):R817-24. PubMed ID: 15987483
[TBL] [Abstract][Full Text] [Related]
14. [Plasma and synovial fibronectin. Results of personal research].
Lecocq J; North ML; Grange D; Hauptmann G; Kuntz JL; Meyer R; Asch L
Rev Rhum Mal Osteoartic; 1984; 51(7-8):393-8. PubMed ID: 6494778
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and metabolism of non-steroidal anti-inflammatory drugs.
Graham GG
Med J Aust; 1987 Dec 7-21; 147(11-12):597-602. PubMed ID: 3320710
[No Abstract] [Full Text] [Related]
16. [Prostaglandins E2 and F2 alpha concentrations in the synovial fluid in rheumatoid and traumatic knee joint diseases].
Egg D; Günther R; Herold M; Kerschbaumer F
Z Rheumatol; 1980; 39(5-6):170-5. PubMed ID: 7415586
[TBL] [Abstract][Full Text] [Related]
17. [The status of various indicators of the protease inhibitor system in blood and synovial fluid in rheumatoid arthritis].
Danilova TG; Platonova LV; Paskhina TS
Vopr Med Khim; 1993; 39(3):40-3. PubMed ID: 8101408
[TBL] [Abstract][Full Text] [Related]
18. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
Deneke J; Luckow V; Guserle R; Pässler HH
Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
[TBL] [Abstract][Full Text] [Related]
19. Cytologic, cytochemical and immunocytochemical pattern of synovial fluid in rheumatoid arthritis, in related diseases and in posttraumatic effusions.
Brühl W; Abgarowicz EM; Chwalińska-Sadowska H; Jakubowski S; Kalczak M; Maldyk H; Wagner T
Reumatologia; 1970; 8(2):89-93. PubMed ID: 4915236
[No Abstract] [Full Text] [Related]
20. Gentisic acid, an aspirin metabolite, inhibits oxidation of low-density lipoprotein and the formation of cholesterol ester hydroperoxides in human plasma.
Ashidate K; Kawamura M; Mimura D; Tohda H; Miyazaki S; Teramoto T; Yamamoto Y; Hirata Y
Eur J Pharmacol; 2005 Apr; 513(3):173-9. PubMed ID: 15862799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
